
Oscar Health (OSCR) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
2.9B
Net Income
-228.5M
-7.98%
EPS (Diluted)
$-0.89
Balance Sheet Metrics
Total Assets
5.8B
Total Liabilities
4.5B
Shareholders Equity
1.3B
Debt to Equity
3.37
Cash Flow Metrics
Operating Cash Flow
377.9M
Free Cash Flow
869.5M
Revenue & Profitability Trend
Oscar Health Income Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Revenue | 9.2B | 5.9B | 4.1B | 1.9B | 589.6M |
Cost of Goods Sold | - | - | - | - | - |
Gross Profit | - | - | - | - | - |
Gross Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Operating Expenses | |||||
Research & Development | - | - | - | - | - |
Selling, General & Administrative | 1.8B | 339.7M | 309.8M | 265.1M | 166.7M |
Other Operating Expenses | 105.0K | 297.8M | 279.1M | 140.3M | 81.5M |
Total Operating Expenses | 1.8B | 637.5M | 588.9M | 405.4M | 248.1M |
Operating Income | - | - | - | - | - |
Operating Margin % | 0.0% | 0.0% | 0.0% | 0.0% | 0.0% |
Non-Operating Items | |||||
Interest Income | - | - | - | - | - |
Interest Expense | 23.7M | 24.6M | 22.6M | 4.7M | 3.5M |
Other Non-Operating Income | - | - | 3.9M | 5.3M | 1.1M |
Pre-tax Income | 33.4M | -267.3M | -610.1M | -570.6M | -405.8M |
Income Tax | 7.3M | 3.3M | -523.0K | 846.0K | 1.0M |
Effective Tax Rate % | 21.9% | 0.0% | 0.0% | 0.0% | 0.0% |
Net Income | 26.1M | -270.6M | -609.6M | -571.4M | -406.8M |
Net Margin % | 0.3% | -4.6% | -14.8% | -29.7% | -69.0% |
Key Metrics | |||||
EBITDA | - | - | - | - | - |
EPS (Basic) | $0.10 | $-1.22 | $-2.85 | $-3.20 | $-14.16 |
EPS (Diluted) | $0.10 | $-1.22 | $-2.85 | $-3.20 | $-14.16 |
Basic Shares Outstanding | 265853000 | 221655493 | 212474615 | 178967056 | 29263424 |
Diluted Shares Outstanding | 265853000 | 221655493 | 212474615 | 178967056 | 29263424 |
Income Statement Trend
Oscar Health Balance Sheet From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 1.5B | 1.9B | 1.6B | 1.1B | 826.3M |
Short-term Investments | 624.5M | 689.8M | 1.4B | 587.1M | 366.4M |
Accounts Receivable | 607.4M | 442.5M | 1.1B | 570.4M | 65.3M |
Inventory | - | - | - | - | - |
Other Current Assets | - | - | - | - | - |
Total Current Assets | - | - | - | - | - |
Non-Current Assets | |||||
Property, Plant & Equipment | - | - | - | - | - |
Goodwill | - | - | - | - | - |
Intangible Assets | - | - | - | - | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | - | - | - | - | - |
Total Non-Current Assets | - | - | - | - | - |
Total Assets | 4.8B | - | - | - | - |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 1.4B | 1.0B | 1.4B | 718.8M | 655.2M |
Short-term Debt | - | - | - | - | - |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | - | - | - | - | - |
Total Current Liabilities | - | - | - | - | - |
Non-Current Liabilities | |||||
Long-term Debt | 299.6M | 298.8M | 298.0M | - | 142.5M |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | - | - | - | - | - |
Total Non-Current Liabilities | - | - | - | - | - |
Total Liabilities | 3.8B | - | - | - | - |
Equity | |||||
Common Stock | 2.0K | 2.0K | 2.0K | 2.0K | 2.0K |
Retained Earnings | -2.9B | -2.9B | -2.6B | -2.0B | -1.4B |
Treasury Stock | 2.9M | 2.9M | 2.9M | 2.9M | 2.9M |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 1.0B | 806.1M | 892.4M | 1.4B | -1.3B |
Key Metrics | |||||
Total Debt | 299.6M | 298.8M | 298.0M | 0 | 142.5M |
Working Capital | 0 | 0 | 0 | 0 | 0 |
Balance Sheet Composition
Oscar Health Cash Flow Statement From 2020 to 2024
Metric | 2024 | 2023 | 2022 | 2021 | 2020 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 26.1M | -270.6M | -609.6M | -571.4M | -406.8M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | 109.8M | 159.7M | 112.3M | 86.3M | 35.9M |
Working Capital Changes | -56.0M | 251.7M | -271.2M | 20.2M | -115.8M |
Operating Cash Flow | 77.3M | 169.5M | -765.6M | -444.9M | -479.1M |
Investing Activities | |||||
Capital Expenditures | -27.9M | -25.6M | -29.0M | -25.9M | -14.0M |
Acquisitions | - | - | - | - | - |
Investment Purchases | -2.1B | -837.0M | -1.2B | -1.8B | -1.0B |
Investment Sales | 770.0M | 1.4B | 994.1M | 1.1B | 671.6M |
Investing Cash Flow | -1.4B | 577.2M | -226.5M | -774.5M | -344.7M |
Financing Activities | |||||
Share Repurchases | - | - | - | 0 | 0 |
Dividends Paid | - | - | - | - | - |
Debt Issuance | 0 | 0 | 305.0M | 0 | 147.0M |
Debt Repayment | - | 0 | 0 | -153.2M | 0 |
Financing Cash Flow | 0 | 2.5M | 299.8M | 1.2B | 517.8M |
Free Cash Flow | 950.3M | -297.7M | 351.3M | -207.6M | 208.7M |
Net Change in Cash | -1.3B | 749.2M | -692.3M | -39.4M | -306.0M |
Cash Flow Trend
Oscar Health Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
34.55
Forward P/E
27.65
Price to Book
3.45
Price to Sales
0.37
PEG Ratio
-0.07
Profitability Ratios
Profit Margin
-1.50%
Operating Margin
-8.05%
Return on Equity
-13.96%
Return on Assets
-1.42%
Financial Health
Current Ratio
0.89
Debt to Equity
30.76
Beta
1.86
Per Share Data
EPS (TTM)
$-0.69
Book Value per Share
$4.49
Revenue per Share
$42.98
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
oscr | 4.0B | 34.55 | 3.45 | -13.96% | -1.50% | 30.76 |
UnitedHealth | 279.4B | 13.35 | 2.95 | 21.65% | 5.04% | 75.58 |
CVS Health | 87.0B | 19.11 | 1.12 | 5.88% | 1.18% | 106.67 |
Molina Healthcare | 9.4B | 8.57 | 2.04 | 23.92% | 2.71% | 77.41 |
Alignment Healthcare | 3.0B | -22.24 | 21.47 | -38.53% | -1.53% | 233.85 |
Cigna | 79.2B | 16.28 | 1.97 | 13.18% | 1.92% | 76.10 |
Financial data is updated regularly. All figures are in the company's reporting currency.